Navigation Links
World Health Day Emphasis on Antimicrobial Resistance Brings Much-Needed Awareness to Alarming Issue
Date:4/7/2011

FRANKLIN LAKES, N.J., April 7, 2011 /PRNewswire/ -- Antimicrobial resistance – also known as drug resistance – is a growing problem that increasingly threatens the health of populations worldwide. Today, World Health Day 2011, the World Health Organization (WHO) is calling on governments and stakeholders to implement the policies and practices needed to prevent and counter the emergence of highly resistant microorganisms. BD (Becton, Dickinson and Company), a leading global medical technology company, applauds the WHO's focus on this issue and is committed to helping fight the problem.

"The continued growth of drug resistance worldwide is unsettling," said Vincent A. Forlenza, BD President and Chief Operating Officer.  "Combating it effectively will require a collaborative, multi-pronged effort from governments, the healthcare community, industry, non-governmental organizations and patient advocacy groups.  We commend the WHO for taking the lead in raising awareness of this important issue on World Health Day and stand ready to apply our technologies and expertise to help address it."

Greater attention to antibiotic stewardship and infection prevention protocols will help curb the growing impact of resistance. Through collaborations, advocacy and technology, BD is dedicated to enhancing antibiotic stewardship worldwide.  Highlights include:

  • Serving as a strategic partner to the Association for Professionals in Infection Control and Epidemiology (APIC).  In this collaboration, BD helps APIC advance its mission by supporting educational programs and initiatives to benefit the infection prevention community.
  • Collaborating with the Foundation for Innovative New Diagnostics to ensure access to improved tuberculosis (TB) diagnostics in resource-limited settings highly burdened by drug-resistant TB.  Faster, accurate diagnosis of TB reduces the time spent on inappropriate and ineffective patient treatment, which can lead to further drug resistance. 

About Antimicrobial Resistance

Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi and parasites change in ways that render the medications used to cure the infections they cause ineffective. When the microorganisms become resistant to most antimicrobials they are often referred to as "superbugs." This is a major concern because a resistant infection may kill, spread to others, and impose huge costs to individuals and society.  For more information, visit www.who.int.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Contact:
Alyssa Zeff
Public Relations
+1 (201) 847-4358 (office)
+1 (917) 273-3685 (mobile)
Alyssa_Zeff@bd.com


'/>"/>
SOURCE BD-Becton Dickinson
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Aspirin Named 8th World Wonder by Majority of Americans
3. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
4. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
5. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
6. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
7. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
8. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
11. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
Breaking Medicine Technology:
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):